etoposide has been researched along with prednisolone in 420 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (7.86) | 18.7374 |
1990's | 143 (34.05) | 18.2507 |
2000's | 120 (28.57) | 29.6817 |
2010's | 102 (24.29) | 24.3611 |
2020's | 22 (5.24) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Thakker, DR; Troutman, MD | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Shaw, MT | 1 |
Dommann, C; Gebbers, JO; Honegger, HP; Joss, R; Kroner, T; Maurer, R; Peters, J; Pichert, G; Stahel, RA; Sulser, H | 1 |
Howells, DW; Hyland, K; Smith, I; Strobel, S | 1 |
Bellman, SC; Brock, PR; Pritchard, J; Yeomans, EC | 1 |
Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S | 1 |
Dartsch, PC; Hombach, V; Kochs, M; Osterhues, H; Roth, D; Seitzer, U; Voisard, R | 1 |
Ezaki, K; Hirano, M; Ino, T; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Shimizu, K; Shinkai, K; Sobue, R | 1 |
Camitta, BP; Clavell, LA; Gelber, RD; Grier, HE; Link, MP; Weistein, HJ | 1 |
Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF | 1 |
Ezaki, K; Hirano, M; Maruyama, F; Okamoto, M | 1 |
Mizoguchi, H; Saito, H | 1 |
Alberto, P; Mermillod, B; Zulian, GB | 1 |
Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S | 1 |
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
Itatani, H; Itoh, H; Takatera, H; Tsujimura, T; Utsunomiya, M | 1 |
Horiuti, A; Kakishita, E; Kanamaru, A; Masaoka, T; Miyazaki, E; Nagai, K; Shibata, H; Takemoto, Y; Tsubaki, K; Yonezawa, T | 1 |
Iki, S; Mitani, K; Ohbayashi, Y; Sato, H; Tamura, M; Urabe, A; Yagisawa, M | 1 |
Kingston, J; Malpas, J; McElwain, TJ; Meller, S; Mott, M; O'Brien, ME; Pinkerton, CR; Radford, M; Tait, D | 1 |
Oguro, M; Sakai, C; Takagi, T | 1 |
Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S | 1 |
Anderson, L; Bennett, MH; Hancock, BW; Haybittle, JL; Linch, DC; MacLennan, KA; Vaughan Hudson, B; Vaughan Hudson, G | 1 |
McElwain, TJ; Meldrum, M; Milan, S; Perren, TJ; Selby, PJ | 1 |
Capnist, G; Chisesi, T; Contu, A; Coser, P; Porcellini, A; Rancan, L; Rizzoli, V; Salvagno, L; Santini, G; Sertoli, M | 1 |
Abbadessa, V; Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Gobbi, PG; Leone, G; Lombardo, M; Moretti, G; Pitini, V | 1 |
Dartsch, PC; Hombach, V; Kochs, M; Roth, D; Seitzer, U; Voisard, R | 1 |
Crowther, D; Radford, JA | 1 |
Fujita, K; Harada, H; Miyoshi, Y; Mori, H; Niikura, H; Okada, S; Shimizu, T; Takizawa, Y; Terada, H | 1 |
Bruntsch, U; Eschenbach, I; Gropp, C; Köppler, H; Lötzke, E; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, EU; Zeller, W | 1 |
Istvan, L; Marton, E | 1 |
Kaneko, Y; Kawai, S; Kondo, M; Mimaya, J; Tonouchi, T; Toyoda, Y; Ueda, R | 1 |
Carey, PJ; Jackson, GH; Lennard, AL; Proctor, SJ | 1 |
Ito, T; Komatsu, M; Saito, Y; Takahashi, H; Toyota, T; Uzuka, Y | 1 |
Howells, DW; Hyland, K; Levinsky, RJ; Smith, I; Strobel, S | 1 |
Magee, B; Read, G; Wilkinson, PM | 1 |
Bergerat, JP; Duclos, B; Dufour, P; Garcia, JJ; Herbrecht, R; Oberling, F | 1 |
Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M | 1 |
Cunningham, D; Forrest, GJ; Gilchrist, NL; Soukop, M | 1 |
Kanai, M; Kanno, M; Kobayashi, K; Kondo, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okafuji, K; Yoshida, T | 1 |
Kyo, T; Maehama, S | 1 |
Akahoshi, Y; Asou, N; Fujimoto, K; Fukuda, S; Ishimaru, S; Kawano, F; Murai, C; Sawatari, T; Taen, A; Takatsuki, K | 1 |
Kano, Y; Masaoka, T; Mikuni, C; Sakamoto, S; Sampi, K; Takagi, T | 1 |
Eschenbach, I; Gassel, WD; Hässler, R; Kolb, T; Köppler, H; Lennert, K; Pfab, R; Pflüger, KH; Schmidt, M; Wellens, W | 1 |
Bagshawe, KD; Begent, RH; Boesen, E; Glaser, MG; Ledermann, JA; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
Coe, MA; Errington, RD; Green, JA; Nash, JR; Warenius, HM | 1 |
Broadbent, V; Dunger, DB; Grant, DB; Lightman, SL; Pritchard, J; Seckl, JR; Yeoman, E | 1 |
Hoshino, T; Kimura, K; Moriya, H; Yaginuma, K | 1 |
Nishizaki, H; Sumida, M | 1 |
Imura, H; Ino, T; Ito, N; Kojima, H; Maruyama, F; Matsui, T; Shimizu, K; Shinkai, K; Shirakawa, S; Sobue, R | 1 |
Hirai, J; Itoh, K; Kanno, M; Kobayashi, K; Matsuda, T; Naito, K; Nakamura, E; Nakamura, S; Ohtake, S; Yoshida, T | 1 |
Matthias, FR; Mueller, IR; Voss, R | 1 |
Hirai, J; Itoh, K; Kanno, M; Kobayashi, K; Matsuda, T; Nakamura, S; Ohtake, S; Saito, Y; Tachimori, K; Yoshida, T | 2 |
Gray, R; Rees, JK | 1 |
Hayashi, K; Kimura, I; Murashima, M; Ohnoshi, T; Tada, A; Ueno, K; Ueoka, H; Yamane, T; Yoshida, M | 2 |
Fujii, H; Iwai, M; Kashiwadani, M; Maekawa, T; Miyoshi, M; Suyama, Y; Urata, Y | 1 |
Horikoshi, N; Imajo, K; Inagaki, J; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Ueno, K; Yamazaki, H | 1 |
Ogawa, M | 1 |
Brix, F; Dühmke, E; Euler, HH; Gassmann, W; Gremmel, H; Hebbinghaus, D; Kayser, W; Schaub, J; Schmitz, N; Wüstemann, M | 1 |
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T | 1 |
Hancock, BW | 1 |
Hiraki, S; Kimura, I; Miyamoto, H; Murashima, M; Ohnoshi, T; Toyata, K; Ueno, K; Ueoka, H; Yamane, T | 1 |
Groth, O; Hellbe, L; Holst, R; Knudsen, EA; Molin, L; Roupe, G; Schmidt, H; Thomsen, K; Volden, G | 1 |
Eddleston, B; Johnson, RJ; Read, G; Wilkinson, PM | 1 |
Hattori, K; Ito, K; Kobayashi, S; Nakamura, S; Nakanishi, J; Ohtake, S; Yoshida, T | 1 |
Callen, JP; Roth, DJ; Williams, BJ | 1 |
Blackledge, GR; Child, JA; Cullen, MH; Fletcher, J; Grieve, RJ; Jones, EL; Murphy, A; Stuart, NS; Woodroffe, C | 1 |
Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C | 1 |
Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR | 1 |
Daguenel, A; Gorin, NC; Laporte, JP; Lesage, S; Najman, A; Parlier, Y; Woler, M | 1 |
Fisher, RI | 2 |
Bosly, A; Coiffier, B; D'Agay, MF; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Nouvel, C; Tilly, H | 1 |
Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK | 1 |
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
Kaya, H; Kumabashiri, I; Matsuda, T; Nakamura, S; Ohtake, S; Yamazaki, H | 1 |
Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N | 1 |
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 1 |
Björkholm, M; Gahrton, G; Grimfors, G; Gruber, A; Hast, R; Järnmark, M; Juliusson, G; Killander, A; Kimby, E; Liliemark, J | 1 |
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
Arnott, S; Crowther, D; Deakin, DP; Gupta, RK; James, RD; Oza, A; Radford, JA; Rohatiner, AZ; Ryder, WD; Wilkinson, PM | 1 |
Watkins, SM | 1 |
Klapper, P; Morris, D; Schofield, K | 1 |
Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM | 1 |
Hayashi, K; Kawashima, K; Matsutomo, S; Mizuta, J; Ohnoshi, T; Saito, S; Tada, A; Tagawa, S; Ueno, K; Yoshino, T | 1 |
Ezoe, A; Fujisaki, Y; Hayashi, S; Kohda, K; Nakazawa, O; Takayanagi, N; Takeda, M; Takimoto, R; Tsuji, A; Tsuji, Y | 1 |
Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H | 1 |
Cowpe, JG; Lewis, MA; Thomas, DW | 1 |
Fujimoto, T; Kikuchi, M; Shimizu, H; Takaue, Y; Takeda, T; Utsumi, J | 1 |
Eguchi, H; Ikuno, Y; Inada, H; Ishii, E; Koga, H; Matuzaki, A; Miyazaki, S; Nibu, K; Okamura, J; Ueda, K | 1 |
Clark, ST; Crowther, D; Radford, JA; Shalet, SM; Swindell, R | 1 |
Catovsky, D; Cunningham, D; Gore, M; Hill, M; Horwich, A; Mansi, J; Milan, S; Selby, P; Smith, I; Zulian, G | 1 |
Green, JA; Pendleton, N | 1 |
Adams, JE; Clark, ST; Crowther, DC; Holmes, SJ; Shalet, SM; Whitehouse, RW | 1 |
Harada, H; Higuchi, T; Maeda, T; Miyoshi, Y; Mori, H; Niikura, H; Okada, S; Shimizu, T; Tada, J; Takahashi, N | 1 |
Arai, T; Fukutoku, M; Hirose, Y; Konda, S; Masaki, Y; Shimizu, S; Sugai, S; Takeshita, S; Takiguti, T; Yoshioka, R | 1 |
Fairey, AF; Jones, HW; Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
Birkmann, J; Eschenbach, I; Gropp, C; Holle, R; Köppler, H; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, UE; Zeller, W | 1 |
Anderson, L; Hancock, BW; Linch, DC; MacLennan, KA; Vaughan Hudson, B; Vaughan Hudson, G | 1 |
Ariad, S; Bezwoda, MA; Bezwoda, WR; Dansey, R; Seymour, L | 1 |
Adachi, S; Akiyama, Y; Hirota, H; Kubota, M; Kuwakado, K; Matsubara, K; Mikawa, H; Wakazono, Y | 1 |
Fukazawa, M; Hashimoto, S; Ishii, A; Kawano, E; Kogure, K; Matsuura, Y; Nakamura, H; Nishimura, M; Oh, H; Okuyama, Y | 1 |
Kobayashi, K; Kyohda, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okabe, Y; Okumura, H; Yoshida, T | 1 |
Ashley, S; Catovsky, D; Cunningham, D; Gore, ME; Hickish, T; Mansi, J; Nicolson, V; Roldan, A; Smith, IE | 1 |
Bailey, CC; Curzon, ME; Duggal, MS; Hart, P; O'Sullivan, EA | 1 |
McKendrick, JJ; Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA | 1 |
Chisesi, T | 1 |
Donaldson, SS; Greenwald, C; Hudson, MM; Humphrey, WA; Kun, L; Marina, NM; Rupp, C; Tarbell, NJ; Weinstein, HJ; Wilimas, J | 1 |
Fujimoto, J; Meguro, T; Miura, T; Nakamura, M; Tsunematsu, Y; Yamada, K | 1 |
Fujita, M; Kawakami, Y; Kobayashi, S; Munakata, M; Nasuhara, Y | 1 |
Hirakawa, K; Horiike, S; Kaneko, H; Kashima, K; Misawa, S; Nakai, H; Nakao, M; Taniwaki, M; Ueda, Y | 1 |
Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
Kamijima, S; Kato, Y; Kobayashi, H; Kuwahara, M; Mihara, H; Nagasaka, T; Oguri, T; Takeda, H | 1 |
Hirose, M; Kuroda, Y; Saito, S; Yoshimoto, T | 1 |
Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
Hirokawa, M; Lee, M; Miura, AB; Motegi, M | 1 |
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
Crowther, D; Deakin, DP; Harris, M; Morgenstern, GR; Pettengell, R; Radford, JA; Ryder, D; Scarffe, JH; Wilkinson, PM; Woll, PJ | 1 |
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J | 1 |
Kumagai, K; Sakai, C; Takagi, T; Wakatsuki, S | 1 |
Fujioka, S; Kato, K; Tomono, H | 1 |
Anderson, L; Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; MacLennan, KA; Milligan, DW; Newland, AC; Stevenson, PA; Vaughan Hudson, B; Vaughan Hudson, G; Wood, JK | 1 |
Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M | 1 |
Nishikawa, K | 1 |
Taguchi, H | 1 |
Doi, T; Kobayashi, D; Koike, K; Kougo, Y; Matsunaga, T; Muramatsu, H; Niitsu, Y; Sakamaki, S; Sato, T; Watanabe, N | 1 |
Hasegawa, S; Inoue, T; Ishibashi, M; Ishida, M; Katoh, M; Koike, M; Maeba, T; Ohwada, S; Sano, F; Takahashi, M; Tuji, K | 1 |
Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
Ezaki, K; Hirano, M; Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Tsuzuki, M; Wakita, M; Yamaguchi, T | 1 |
Armata, J; Grześkowiak-Melanowska, J; Skoczeń, S | 1 |
Akatsuka, J; Fujisawa, K; Hoshi, Y; Hurusato, M; Kobayashi, H; Maekawa, K; Uchiyama, H; Urashima, M | 1 |
Ando, T; Ariyoshi, K; Hikiji, K; Kobayashi, M; Shinohara, K; Toyosawa, M | 1 |
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
Havemann, K; Kaiser, U; Pfab, R | 1 |
Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K | 1 |
Golding, PF; Hamilton, CR; Kerr, J; Mead, GM; Milne, AE; O'Callaghan, A; Simmonds, PD; Smartt, P; Sweetenham, JW; Whitehouse, JM | 1 |
Bezwoda, WR; Dansey, R; Davidge-Pitts, M | 1 |
Aranguren, PN; Ardaiz, MC; Bruno, S; Cancela, ME; Cerutti, I; Corrado, C; Dibar, E; Donato, H; Lastiri, F; Magnasco, H; Pavlovsky, S; Raslawski, E; Rosso, A; Salvarezza, A; Schvartzman, E; Zirone, S | 1 |
Angus, B; Cameron, DA; Cook, MK; Dawes, PJ; Dawson, AA; Evans, RG; Galloway, MJ; Harris, AL; Heppleston, A; Horne, CH; Krajewski, AS; Lennard, AL; Leonard, RC; Lessells, AM; Lucraft, HH; MacGillivray, JB; Mackie, MJ; Parker, AC; Prescott, RJ; Proctor, SJ; Roberts, JT; Taylor, PR; Thompson, WD; White, JM | 1 |
Alderete, D; Alfaro, E; Casak, S; Chantada, G; Felice, MS; Gallo, G; Quinteros, R; Sackmann-Muriel, F; Scopinaro, M; Zubizarreta, P | 1 |
Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M | 1 |
Hoskin, PJ | 1 |
Asami, K; Eguchi, H; Hatae, Y; Hirota, T; Iwai, A; Katano, N; Koizumi, S; Kono, Y; Matusita, T; Miyawaki, T; Mugisima, H; Nakayama, M; Nisikawa, K; Osima, K; Sekine, I; Simokawa, T; Suzumiya, J; Tanaka, A; Tsuchiya, T; Tsurusawa, M; Utumi, J; Yamamoto, Y; Yamamura, Y; Yanase, T; Yokota, S | 1 |
Colomer, R; Gómez, H | 1 |
Anderson, E; Eden, O; Isaksson, O; Robson, H; Shalet, S | 1 |
Anderson, E; Eden, OB; Isaksson, O; Robson, H; Shalet, S | 1 |
Bailey, C; Burrett, J; Chessells, J; Hann, I; Hill, F; Richards, S | 1 |
Almqvist, A; Elonen, E; Hänninen, A; Jansson, SE; Järventie, G; Koistinen, P; Koivunen, E; Lahtinen, R; Lehtinen, M; Nousiainen, T; Pelliniemi, TT; Rajamäki, A; Remes, K; Ruutu, T; Timonen, T; Vilpo, J; Volin, L | 1 |
Bailey, NP; Barnard, DL; Bessell, EM; Child, JA; Cullen, MH; Dunn, J; Farish, J; Fletcher, J; Grieve, RJ; Jack, A; Norfolk, D; Simmons, AV; Stack, C; Stuart, NS; Woodroffe, CM | 1 |
Bloor, AJ; Marcus, RE; Seale, JR | 1 |
Blumenstengel, K; Fricke, HJ; Höffken, K; Kath, R; Kunert, C; Sayer, HG; Vogel, W | 1 |
Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C | 1 |
Baltali, E; Barişta, I; Celik, I; Firat, D; Güler, N; Güllü, I; Kars, A; Ozişik, Y; Ozyilkan, O; Tekuzman, G; Yalçin, S | 1 |
Biersack, HJ; Grünwald, F; Palmedo, H; Ruhlmann, J; Willkomm, P | 1 |
Chen, JS; Chen, RL; Jou, ST; Lin, DT; Lin, KH; Su, IJ | 1 |
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
Hayashi, T; Kugimiya, T; Miyahara, Y; Takagi, M | 1 |
Akashi, T; Fukutomi, M; Funakoshi, A; Iguchi, H; Kuniyoshi, M; Ohnishi, Y; Wakasugi, H; Yokota, M | 1 |
Abe, T; Arai, K; Arakawa, H; Asami, K; Hasegawa, D; Henter, JI; Hibi, S; Hisakawa, H; Ichimi, R; Igarashi, N; Imashuku, S; Iwai, A; Kataoka, S; Kato, M; Kawasaki, H; Kosaka, Y; Maeda, N; Maruhashi, K; Miyashita, H; Ohara, T; Sako, M; Sano, K; Sotomatsu, M; Tanizawa, A | 1 |
Ashley, S; Atra, A; Kingston, JE; Mott, M; Pinkerton, CR; Shankar, AG | 1 |
Asano, S; Matsuoka, M; Ohata, J; Tani, K; Tojo, A; Yamashita, T | 1 |
Economopoulos, T; Fountzilas, G; Pavlidis, N; Raptis, S; Samantas, E; Xiros, N | 1 |
Downie, P; Ekert, H; Macfarlane, S; Smith, PJ; Toogood, I; White, L | 1 |
Cavalli, F; Gueneau, M; Martinelli, G; Peccatori, F; Saletti, P; Zucca, E | 1 |
Barnett, M; Connors, JM; Gascoyne, RD; Horsman, D; Klasa, R; Lesack, D; Macpherson, N | 1 |
Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G | 1 |
Benboubker, L; Bout, M; Cartron, G; Colombat, P; Delain, M; Lamagnere, JP; Linassier, C | 1 |
Hasegawa, D; Hayakawa, A; Kosaka, Y; Nakamura, H; Sano, K | 1 |
Arita, K; Harada, K; Ide, T; Kurisu, K; Sadatomo, T; Tahara, E; Tahara, H; Uozumi, T | 1 |
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F | 1 |
Bellido, T; Manolagas, SC; Parfitt, AM; Plotkin, LI; Roberson, PK; Weinstein, RS | 1 |
Arima, N; Fujiwara, H; Hidaka, S; Imamura, N; Kukita, T; Matsumoto, M; Matsumoto, T; Matsushita, K; Ohtsubo, H; Tei, C | 1 |
Ozbek, N; Tuncer, AM; Yetgin, S | 1 |
Cavenagh, JD; Eden, AG; Hughes, A; Kelsey, SM; Lamont, A; McBride, NC; Mills, MJ; Newland, AC; Ward, MC | 1 |
Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; Maclennan, KA; Milligan, D; Newland, AC; Smith, P; Stevenson, PA; Vaughan, B; Vaughan, G; Wood, JK | 1 |
Bhargava, V; Das, BK; Datta, V; Kumar, M; Mishra, OP; Singla, PN | 1 |
Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A | 1 |
Akiyama, H; Asou, N; Kitamura, K; Kiyoi, H; Kuriyama, K; Kusumoto, S; Minami, S; Miyawaki, S; Motoji, T; Nakano, Y; Naoe, T; Nishimura, M; Ohno, R; Saito, H; Saito, K; Shimazaki, C; Shinagawa, K | 1 |
Hirano, M; Kodama, F; Kuraishi, Y; Nakamura, S; Niitsu, N; Okamoto, M | 1 |
Barriga, F; García, C; González, S; Holmgren, NL; Méndez, M; Sánchez, I | 1 |
Hashida, T; Hibi, S; Imashuku, S; Ishimoto, K; Itoh, E; Kawano, F; Tabata, Y; Tsunamoto, K | 1 |
Hirata, M; Kanda, M; Kikuchi, M; Kumagawa, M; Nagano, M; Nawa, Y; Ohshima, K; Suzumiya, J; Tamura, K | 1 |
Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M | 1 |
Fujimura, T; Hamada, Y; Haraguchi, F; Katsuoka, K; Ma, G; Masuzawa, M; Sakurai, Y; Tamauchi, H | 1 |
Bajwa, RP; Reid, MM; Skinner, R; Wariyar, UK; Windebank, KP | 1 |
Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G | 1 |
Hsia, SH; Hsueh, C; Hung, IJ; Jaing, TH; Kao, CC; Tain, YL | 1 |
Janjindamai SHirunpat, S; Maipang MVasiknanonte, P | 1 |
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A | 1 |
Cunningham, D; Gregory, W; Hancock, B; Hoskin, P; Hudson, GV; Linch, D; MacLennan, K; Mainwaring, PN; Norton, AJ; Smith, P | 1 |
Arima, N; Doi, S; Fujimoto, M; Fukuhara, S; Hayashi, K; Katsurada, T; Kitajima, H; Konaka, Y; Moriguchi, T; Nasu, K; Ohno, H; Tsudo, M | 1 |
Bessell, EM; Burton, A; Cullen, MH; Gregory, WM; Hancock, BW; Hudson, GV; Jack, A; Linch, DC; Maclennan, KA; Selby, P; Smith, P | 1 |
Daibata, M; Hatakeyama, N; Hiroi, M; Kamioka, M; Miyoshi, I; Nemoto, Y; Taguchi, H | 1 |
Kanda, Y; Mineishi, S; Murakami, J; Ogasawara, T; Saito, T; Seo, S; Shoji, N; Takaue, Y; Tanosaki, R; Tobinai, K | 1 |
Akiyoshi, K; Ayukawa, H; Eguchi, H; Ishii, E; Kamizono, J; Kawakami, K; Kinukawa, N; Koga, H; Kuroda, H; Matsuzaki, A; Okamura, J; Tamai, Y; Yanai, F | 1 |
Creutzig, U; de Vries, E; Hählen, K; Huismans, DR; Janka-Schaub, GE; Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ; Zwaan, CM | 1 |
Baudis, M; Bentz, M; Döhner, H; Fritz, B; Kloess, M; Lichter, P; Schwänen, C; Walenta, K; Wessendorf, S | 1 |
Klöss, M; Loeffler, M; Nguyen, TP; Pfreunschuh, M; Rübe, C; Trümper, L | 1 |
Chao, TY; Chen, YC; Ho, CL; Hwang, JM; Kao, WY; Sheu, LF | 1 |
Akiyama, H; Asou, N; Kiyoi, H; Kodera, Y; Kuriyama, K; Kusumoto, S; Miyawaki, S; Motoji, T; Naoe, T; Nishimura, M; Ohno, R; Saito, H; Saito, K; Shimazaki, C; Shinagawa, K; Tagawa, Y; Ueda, R | 1 |
Ariatti, C; Bertini, M; Boccomini, C; Botto, B; Calvi, R; Capello, D; Carbone, A; Freilone, R; Gaidano, G; Gallo, E; Gloghini, A; Milan, I; Novero, D; Orsucci, L; Palestro, G; Parvis, G; Pregno, P; Saglio, G; Vitolo, U; Vivenza, D; Zagonel, V | 1 |
Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K | 1 |
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A | 1 |
Ho, AD; Kornacker, M; Kraemer, A; Leo, E | 1 |
Dreger, P; Glass, B; Haas, R; Kneba, M; Kröger, N; Kuse, R; Martin, S; Parwaresch, R; Schmitz, N; Sonnen, R | 1 |
Carde, P; Cavalli, F; Diehl, V; Franklin, J | 1 |
Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R | 1 |
Gerrard, M; Hobson, R; Imeson, J; McCarthy, K; Pinkerton, CR; Williams, DM | 1 |
Brito, G; Fernandez, T; Klumb, C; Land, MG; Maradei, S; Otero, L; Pombo-de-Oliveira, MS; Silva, ML; Veith, M | 1 |
Barbui, T; Chang, J; Cowan, RA; Crowther, D; Deakin, DP; Dunlop, DJ; Gupta, RK; James, RD; Lister, TA; Lucie, NP; Radford, JA; Rohatiner, AZ; Rossi, A; Ryder, WD; Shamash, J; Wilkinson, PM | 1 |
Furukawa, Y; Imanishi, H; Kouzuma, T; Nozawa, T; Sato, K; Sato, T; Yanagihara, M | 1 |
Pranesh, N | 1 |
Gadner, H; Grois, N; Heitger, A; Minkov, M; Pötschger, U; Westermeier, T | 1 |
Abel, U; Baudis, M; Birkmann, J; Bischoff, HG; Franke, A; Grundeis, M; Havemann, K; Hossfeld, DK; Kaiser, U; Karakas, T; Kneba, M; Köppler, H; Krahl, D; Mantovani, L; Mesters, RM; Metzner, B; Müller, P; Parwaresch, R; Pfab, R; Pfreundschuh, M; Reiser, M; Rothmann, F; Schmalenberg, H; Schmitz, N; Schumacher, K; Steinhauer, EU; Trümper, L; Uebelacker, I; von Seydewitz, CU | 1 |
Southcott, BM; Stewart, AJ | 1 |
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
Aoki, Y; Kataoka, C; Nomiyama, K; Shibuya, T | 1 |
Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
Hino, K; Kawakami, K; Matsuda, I; Nakamaki, T; Ota, H; Shiozawa, E; Tomoyasu, S | 1 |
Chang, MC; Chao, TY; Chen, LT; Chen, PJ; Cheng, AL; Hsiung, CA; Hsu, CH; Kao, WY; Su, IJ; Tien, HF; Tsao, CJ; Uen, WC; Whang-Peng, J | 1 |
Griniūte, R; Pileckyte, M | 1 |
Braier, JL; Diez, RA; Ripoli, MF; Rosso, DA; Roy, A; Zelazko, ME | 1 |
Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A | 1 |
Mead, G; Woodcock, J; Young, C | 1 |
Bilsland, D; Dawn, G; Jackson, R; Morrison, A; Morton, R | 1 |
Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
Addicks, K; Lackner, K; Nuss, D | 1 |
Arima, N; Arimura, K; Hamada, H; Kukita, T; Matsushita, K; Tei, C | 1 |
Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K | 1 |
Cowan, RA; Deakin, DP; Harris, MA; James, RD; Radford, JA; Swindell, R | 1 |
Kitanishi, T; Kitano, H; Kouzaki, H; Suzuki, M | 1 |
Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L | 1 |
Fukuhara, S; Ishii, K; Nomura, S; Yamamoto, Y | 1 |
Bain, BJ; Chakravorty, S; Coulter, C; Johnston, R | 1 |
Kawa, K | 1 |
Al-Izzi, M; Constantinou, J; McNicholas, TA; Nitkunan, T | 1 |
Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E | 1 |
Ishiyama, K; Nakao, S; Okumura, H; Ozaki, J; Shimadoi, S; Takami, A; Yamanaka, S | 1 |
Arnaud, P; Bocaccio, C; Bourhis, JH; Carde, P; Ferme, C; Jabbour, E; Koscielny, S; Peslin, N; Ribrag, V; Vantelon, JM | 1 |
Dietl, J; Djakovic, A; Ott, G; Vordermark, D; Zollner, U | 1 |
Cai, Z; Huang, H; Li, L; Lin, MF; Luo, Y; Meng, XJ; Xie, WZ | 1 |
Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
Clawson, S; Cullen, MH; Hancock, BW; Jack, AS; Johnson, PW; MacLennan, KA; Radford, JA; Ryder, D; Smith, P; Stenning, SP; Sydes, MR; Walewski, J | 1 |
Goldstone, A; Hann, I; Mitchell, C; Ramanujachar, R; Richards, S; Rowe, J; Vora, A; Webb, D | 1 |
Mochiduki, Y; Muramoto, S | 1 |
Fukuda, H; Fukuhara, S; Hirose, Y; Hotta, T; Kawano, F; Kikuchi, M; Mizoroki, F; Nakata, M; Nasu, K; Ohno, Y; Sano, M; Sawada, K; Shimoyama, M; Taniwaki, M; Tobinai, K; Togawa, A; Toki, H; Uozumi, K | 1 |
Yamada, Y | 1 |
Fujimaki, K; Fujisawa, S; Fujita, H; Harano, H; Hashimoto, C; Ishigatsubo, Y; Kanamori, H; Kodama, F; Koharazawa, H; Maruta, A; Motomura, S; Sakai, R; Tomita, N | 1 |
Burton, C; Cunningham, D; Dyer, MJ; Hancock, B; Hoskin, P; Jack, A; Linch, D; MacLennan, K; Milligan, D; Mouncey, P; Qian, W; Smith, P; Webb, A | 1 |
Kunihiko, M; Mariko, Y; Shinichiro, O; Yasuo, I; Yusuke, T; Yutaka, H | 1 |
Adde, M; Enblad, G; Hagberg, H; Laurell, A; Sundström, C | 1 |
Belevtsev, MV; Buglova, SE; Shman, TV | 1 |
Titulaer, MJ; van Gerven, J; Verschuuren, JJ; Willems, LN; Wirtz, PW | 1 |
Bjarnason, NH; Dalhoff, K; Jurlander, J | 1 |
Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lau, YL; Shek, TW | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, DW; Kim, NK; Kim, TY; Lee, KW; Park, S; Yoon, SS; Yun, T | 1 |
Alonso Ojembarrena, A; Contra Gómez, T; Díaz Pérez, MA; García Castro, J; González-Vicent, M; Madero López, L; Pérez Martínez, A; Ramírez Orellana, M | 1 |
Aoki, S; Hirano, M; Kohori, M; Miura, I; Niitsu, N; Okamoto, M | 1 |
Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
Haas, A; Hummel, M; Lobeck, H; Maschmeyer, G | 1 |
Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M | 1 |
Hasegawa, M; Hayakawa, I; Ikeda, H; Oishi, N; Sato, S; Shirasaki, F; Takehara, K | 1 |
Ichioka, M; Ishiga, T; Saito, K; Tanigawa, M | 1 |
Furue, M; Hara, T; Ichino, K; Ishimura, M; Nishikomori, R; Ohga, S; Takada, H; Urabe, K | 1 |
Herman, M; Indrák, K; Papajík, T; Paucek, B; Raida, L; Zapletalová, J | 1 |
Ehninger, G; Friedrichsen, K; Haenel, M; Kroschinsky, FP; Mueller, J; Prondzinsky, R; Pursche, S; Schleyer, E | 1 |
Guang, ZZ; Jiang, WQ; Li, ZM; Liu, ZC; Yang, DJ; Zhou, JM; Zhu, XF; Zhu, ZY | 1 |
Herrmann, M; Kneer, H; König, J; Pfreundschuh, M; Widmann, T | 1 |
Fujiwara, M; Higashimura, M; Izumi, N; Koike, T; Satou, N; Shibasaki, Y; Tsukada, N | 1 |
Bentz, M; Dührsen, U; Einsele, H; Lengfelder, E; Loeffler, M; Mergenthaler, HG; Mesters, R; Pflüger, KH; Pfreundschuh, M; Rübe, C; Schmitz, N; Trümper, L; Vrieling, T; Zeynalova, S; Zwick, C | 1 |
Bentz, M; Graeven, U; Hasenclever, D; Hoffmann, M; Hohloch, K; Liersch, R; Loeffler, M; Metzner, B; Mohren, M; Pfreundschuh, M; Schmits, R; Trümper, L; Wruck, U; Ziepert, M; Zwick, C | 1 |
Kono, T; Noguchi, T; Nohara, J; Sakaguchi, Y; Terada, Y | 1 |
Basecke, J; Becker, A; Glass, B; Griesinger, F; Haase, D; Podleschny, M; Schmitz, N; Schwiers, I; Schwiers, R; Seiffert, E; Trumper, L | 1 |
Bang, YJ; Heo, DS; Im, SA; Kim, BK; Kim, BS; Kim, CW; Kim, DW; Kim, NK; Kim, TY; Park, S; Yoon, SS | 1 |
Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S | 1 |
Audhuy, B; Bouabdallah, R; Brice, P; Dartigeas, C; de Guibert, S; Doyen, C; Ferme, C; Feugier, P; Foussard, C; Haioun, C; Mahé, B; Morschhauser, F; Mounier, N; Rossi, JF; Salles, G; Sebban, C; Xerri, L | 1 |
Yamaguchi, M | 1 |
Hirami, Y; Kawagoe, N; Mandai, M; Mio, T; Mishima, M; Sakuma, K; Takahashi, M; Yoshimura, N | 1 |
Jonathan, F | 1 |
Ito, T; Kato, Y; Matsumoto, Y; Tsuboi, R; Wakamatsu, J; Yamamoto, T | 1 |
Brault, P; Decaudin, D; Escande, MC; Girodet, J; Mariani, P; Mathiot, C; Precupanu, CM; Zanni, M | 1 |
Clarke, SJ; Cunningham, D; Dent, O; Robertson, G; Sharma, R; Smith, P | 1 |
Engman, CA; Hill, JM; Meehan, KR | 1 |
Chauvenet, A; Constine, LS; deAlarcon, PA; Hutchison, RE; Lipshultz, SE; London, WB; Schwartz, CL; Sposto, R; Turner, CS; Villaluna, D | 1 |
Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
Akbulut, H; Buyukcelik, A; Demirkazik, A; Dincol, D; Dogan, M; Icli, F; Onur, H; Samur, M; Senler, FC | 1 |
Haapasaari, KM; Kuittinen, O; Kyllönen, H; Pasanen, AK; Turpeenniemi-Hujanen, T | 1 |
Culligan, D; Jackson, GH; Jones, GL; Lennard, AL; Lewis, J; Lucraft, HH; McKay, P; Proctor, SJ; Sieniawski, M; White, J; Wilkinson, J | 1 |
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L | 1 |
Kinoshita, T | 1 |
Cen, XN; Chen, H; Han, MZ; Han, XH; He, XH; Huang, H; Huang, HQ; Jiang, WQ; Liu, P; Ma, J; Ren, HY; Shen, XM; Shi, YK; Wang, C; Wang, JM; Yang, S; Zhou, SY; Zhu, J | 1 |
Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S | 1 |
Boesen, AM; Browett, P; Cunningham, D; Grigg, A; Hancock, B; Holte, H; Hoskin, P; Jack, A; Linch, DC; Maclennan, K; Qian, W; Smith, P; Trneny, M; Yung, L | 1 |
Brockmöller, J; Hoffmann, M; Kreuz, M; Kube, D; Loeffler, M; Pfreundschuh, M; Schirmer, MA; Trümper, L; Tzvetkov, MV; Wojnowski, L; Ziepert, M | 1 |
Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
Bessho, M; Hagiwara, Y; Kohri, M; Niitsu, N; Okamoto, M; Takahashi, N; Tanae, K | 1 |
Ali, ZB; Ben Othmen, T; Bouaouina, N; Daoud, J; Elloumi, M; Ghannem, H; Laatiri, MA; Maalej, M; Meddeb, B; Msadek, F; Toumi, N | 1 |
Kiewe, P; Thiel, E | 1 |
Feller, A; Freund, M; Glass, B; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Schmitz, N; Trümper, L; Ziepert, M | 1 |
Gill, D; Ho, AD; Kuhnt, E; Loeffler, M; Österborg, A; Pettengell, R; Pfreundschuh, M; Rieger, M; Walewski, J; White, D | 1 |
Nakamine, H; Nakamura, N; Nakamura, S; Niitsu, N; Ohshima, K; Okamoto, M; Tamaru, J; Yoshino, T | 1 |
Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
Hayama, M; Nakamine, H; Nakamura, S; Niitsu, N; Okamoto, M; Tamaru, J; Yoshino, T | 1 |
Baumgart, M; Bertsch, HP; Haase, D; Kaune, KM; Mitteldorf, C; Neumann, C; Rosenwald, A; Schön, MP; Wulf, G | 1 |
Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
Kakugawa, Y; Saito, Y; Tanaka, S; Taniguchi, H; Terasaka, S; Watanabe, T | 1 |
Camilleri, MJ; Podjasek, JO | 1 |
Kampfenkel, T; Kreuter, A; Schroers, R | 1 |
Ferreri, AJ; Govi, S; Pileri, SA; Savage, KJ | 1 |
Tsukasaki, K | 1 |
Aurlien, E; Baggerød, E; Bishop, MR; Brinch, L; Dybedal, I; Egeland, T; Fløisand, Y; Fosså, A; Fowler, DH; Gedde-Dahl, T; Heldal, D; Holte, H; Kolstad, A; Kvalheim, G; Lauritzsen, GF; Lehne, G; Tjønnfjord, GE; Torfoss, D | 1 |
Akalan, N; Akyüz, C; Balcı, S; Batu, A; Büyükpamukçu, M; Cila, A; Kutluk, T; Soylemezoğlu, F; Varan, A; Zorlu, F | 1 |
Adachi, Y; Arimura, Y; Endo, T; Ishii, Y; Sawada, T; Yasui, H | 1 |
Bayrakci, B; Carcillo, JA; Citak, A; Demirkol, D; Dursun, O; Erkek, N; Gedik, H; Karabocuoglu, M; Karapinar, B; Kendirli, T; Kesici, S; Koroglu, TF; Yildizdas, D | 1 |
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
Fueki-Yoshioka, H; Hama-Yamamoto, K; Hino, R; Hiromasa, K; Izu, K; Kabashima-Kubo, R; Kobayashi, M; Nakamura, M; Ohmori, S; Okura, R; Sawada, Y; Shimauchi, T; Sugita, K; Tajiri, M; Tokura, Y; Yamada, S; Yamaguchi, T; Yoshiki, R; Yoshioka, M; Yoshizawa, M | 1 |
Arai, A; Fujiwara, S; Imadome, K; Kurata, M; Miura, O; Murakami, N; Nogami, A | 1 |
Bentz, M; Borchmann, P; Doelken, G; Ehninger, G; Glass, B; Haenel, M; Loeffler, M; Nickelsen, M; Peter, N; Pfreundschuh, M; Rosenwald, A; Ruebe, C; Schmidt, C; Schmitz, N; Truemper, L; Viardot, A; Ziepert, M | 1 |
Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
Czyzewski, K; Debski, R; Jaworska-Posadzy, A; Kolodziej, B; Kubicka, M; Kurylo-Rafinska, B; Piatkowska, M; Pogorzala, M; Styczynski, J; Wysocki, M | 1 |
Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
Bachour, M; Hussein, T; Kenj, M; Salamoon, M | 1 |
Escherich, G; Hagel, C; Hartz, B; Löbel, U | 1 |
Imashuku, S; Kubo, K; Kudo, N; Yachie, A | 1 |
Cunningham, D; Linch, DC; Lowry, L; Smith, P | 1 |
Elsner, P; Grimm, MO; Schummer, C; Tittelbach, J; Winkler, Y | 1 |
Chai-Adisaksopha, C; Nawarawong, W; Norasetthada, L; Rattarittamrong, E; Tantiworawit, A | 1 |
Imamura, Y | 1 |
Madsen, HO; Minculescu, L; Sengeløv, H | 1 |
Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL | 1 |
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C | 1 |
Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
Alig, SK; Aulinger, B; Dreyling, M; Rieger, CT; Seppi, B; Witkowski, L | 1 |
Ellin, F; Jerkeman, M; Landström, J; Relander, T | 2 |
Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ | 1 |
Fukushima, T | 1 |
Heo, DS; Jeon, YK; Keam, B; Kim, CW; Kim, DW; Kim, KH; Kim, M; Kim, TM; Lee, JS; Lee, SH | 1 |
Cella, D; Drullinsky, PR; Elstrom, R; Gerecitano, JF; Hamilton, AM; Hamlin, PA; Lia Palomba, M; Matasar, MJ; Noy, A; Straus, DJ; Wegner, B; Wortman, K; Zelenetz, AD | 1 |
Acab, A; Chailangkarn, T; Dietrich, A; Fernandez, TV; Griesi-Oliveira, K; Gu, X; Gupta, AR; Haddad, G; Ji, W; Lifton, RP; Marchetto, MC; Ming, GL; Muotri, AR; Murdoch, JD; Nicol, X; Nunez, Y; Passos-Bueno, MR; Pradhan, D; Sanders, SJ; Song, H; Spitzer, N; State, MW; Sunaga, DY; Vadasz, E; Walker, MF | 1 |
Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
Akinaga, S; Fujiwara, H; Imada, K; Ishida, T; Ishitsuka, K; Jo, T; Miyamoto, T; Moriuchi, Y; Nosaka, K; Saburi, Y; Suzushima, H; Taira, N; Takemoto, S; Tobinai, K; Tomonaga, M; Ueda, R; Uike, N; Uozumi, K; Utsunomiya, A; Yamamoto, K; Yoshida, S | 1 |
Brown, P; Gang, AO; Høgdall, E; Knudsen, H; Lauritzen, AF; Nielsen, SL; Nørgaard, P; Pedersen, M; Pedersen, MØ; Poulsen, TS | 1 |
Kheradpour, A; Rowsell, EH; Wang, J; Weiss, LM; Zhang, H; Zuppan, CW | 1 |
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC | 1 |
Hartman, L; Jerkeman, M; Székely, E; Wästerlid, T | 1 |
Amadori, S; Anemona, L; Bruno, E; Buccisano, F; Cantonetti, M; Del Principe, MI; Franceschini, L; Mauramati, S; Meconi, F; Nasso, D; Onnis, I; Postorino, M; Provenzano, I; Pupo, L; Rizzo, M; Vaccarini, S; Zizzari, A | 1 |
Beaven, AW; Diehl, LF | 1 |
Miyahara, M; Ureshino, H | 1 |
Doğu, MH; Eren, R; Gündoğan, C; Huq, GE; Kantarci, FE; Suyanı, E | 1 |
Adamou, H; Brah, S; Garba, AA; Habou, O; Magagi, IA | 1 |
Bachanova, V; Boland, PJ; Eckfeldt, CE; Hegerova, LT; McKenna, RW; Williams, SJ | 1 |
Björkholm, M; Borrebaeck, CA; Eriksson, M; Fjordén, K; Fluge, Ø; Holte, H; Isinger-Ekstrand, A; Jerkeman, M; Leppä, S; Møller Pedersen, L; Pauly, F; Wingren, C | 1 |
Agostinelli, C; Grandi, V; Patrizi, A; Pellegrini, C; Pileri, A; Pimpinelli, N; Zinzani, PL | 1 |
Kamdar, M; Major, A; Pan, Z | 1 |
Bjerregård Pedersen, M; Cederleuf, H; d'Amore, F; Ellin, F; Jerkeman, M; Relander, T | 1 |
Kamachi, K; Miyahara, M; Ureshino, H | 1 |
Cho, YS; Heo, DS; Jung, SH; Keam, B; Kim, DW; Kim, HJ; Kim, IH; Kim, M; Kim, TM; Lee, JY; Lee, SH; Ock, CY | 1 |
Jandial, A; Malhotra, P; Mishra, K; Nambiyar, K | 1 |
Ailawadhi, S; Dholaria, B; Patel, RJ; Roy, V; Sluzevich, JC | 1 |
Arai, A; Imadome, K; Miura, K; Namiki, T; Tokoro, S; Watanabe, K; Yokozeki, H | 1 |
Kohsaka, H; Komiya, Y; Mizoguchi, F; Saito, T | 1 |
Billett, AL; LaCasce, AS; Marcus, KJ; Ozuah, NW | 1 |
Minkov, M | 1 |
Aoyagi, T; Kaku, M; Kawakami, K; Oshima, K; Sato, Y; Toyama, M | 1 |
Clemens, MW; Horwitz, SM; Mehta-Shah, N | 1 |
Appel, B; Bush, R; Buxton, A; Friedman, DL; Kelly, KM; Marks, LJ; Pei, Q; Schwartz, CL | 1 |
Bettarello, G; Costa, LJM; da Matta Abreu, M; Dos Santos, KB; Hallack Neto, AE; Mayrink, GTC; Mota, MA; Pereira, J; Ribeiro, LC | 1 |
Guenova, ML; Hristoskova, RG; Petkova, NY; Raynov, JI | 1 |
Bono, W; Bouayad, N; Bouhafa, T; Elmazghi, A; Khalid, H; Masbah, O; Oubelkacem, N | 1 |
Kimpton, G; Maybury, B; Otton, S | 1 |
Liu, W; Liu, X; Song, Y; Wu, M; Xie, Y; Yang, M; Zheng, W; Zhu, J | 1 |
Altmann, B; Friedrichs, B; Glass, B; Haenel, M; Lenz, G; Loeffler, M; Nickelsen, M; Pfreundschuh, M; Rosenwald, A; Ruebe, C; Schmidt, C; Schmitz, N; Viardot, A; Ziepert, M | 1 |
Haapasaari, KM; Jantunen, E; Kari, E; Karihtala, P; Kuittinen, O; Kuusisto, MEL; Lemma, A; Pirinen, R; Soini, Y; Teppo, HR; Turpeenniemi-Hujanen, T | 1 |
Belada, D; Bortlicek, Z; Campr, V; Chloupkova, R; Duras, J; Hamouzova, J; Janikova, A; Klener, P; Kopalova, N; Mayer, J; Mocikova, H; Pirnos, J; Prochazka, V; Pytlik, R; Trneny, M | 1 |
Cardarelli, L; Chiaretti, S; Diverio, D; Foà, R; Giona, F; Mancini, F; Miano, M; Moleti, ML; Nanni, M; Palumbo, G; Peragine, N; Santopietro, M; Testi, AM; Zhang, K | 1 |
Ashrani, AA; Higgins, AS; Hoversten, KP | 1 |
Antonioli, E; Bosi, A; Fani, A; Puccini, B; Sordi, B | 1 |
Asad, M; Mehreen, A; Ria, S; Sindhu, II; Wali, RM | 1 |
Charoenprasert, K; Chinthammitr, Y; Kasyanan, H; Panoi, N; Phinyo, P; Pongudom, S; Purattanamal, J; Surawong, A; Wongyai, K | 1 |
Xia, Y; Zhang, X | 1 |
Fiala, MA; Ghobadi, A; Goldsmith, SR; Schroeder, MA; Stockerl-Goldstein, K; Vij, R; Wang, B; Wildes, TM | 1 |
Kobbe, R; Schmidtke, S; Schwärzler, P; Stang, A; Tolosa, E | 1 |
Erbin, A; Guler, Y; Ucpinar, B | 1 |
Arbelbide, J; Barcan, L; Basquiera, AL; Cristaldo, N; García-Rivello, H; Otero, V; Valledor, A; Warley, F | 1 |
Au-Yeung, R; Chan, TSY; Ip, AHW; Kwong, YL; Pang, AWK | 1 |
Camou, F; Gabriel, F; Issa, N; Larroquette, M | 1 |
Behrens, YL; Ganser, A; Göhring, G; Kreipe, HH; Schünemann, C; Thol, F | 1 |
Anagnostopoulos, I; Dalkilic, R; Darr, A; Eisfeld, H; Freesmeyer, M; Gaßler, N; Gühne, F; Hochhaus, A; Hofmann, G; Kalff, R; Kircher, S; Lehmkuhl, L; Rosenwald, A; Schrenk, KG; Teichgräber, U; Werner, M; Weschenfelder, W; Wolf, G | 1 |
Rais, H; Tazi, I; Tissir, R | 1 |
Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R | 1 |
Jiang, Q; Lei, CS; Qiu, L; Yu, Q | 1 |
Altmann, B; Banos, A; Bay, JO; Bilger, K; Bouabdallah, K; Braulke, F; Cartron, G; Damaj, G; de Leval, L; Delmer, A; Dreger, P; Dreyling, M; Friedrichs, B; Gaulard, P; Gisselbrecht, C; Glass, B; Gyan, E; Haenel, M; Jaccard, A; Keller, U; Kroschinsky, F; Lamy, T; Leclerc, M; Lindemann, W; Metzner, B; Milpied, N; Nickelsen, M; Poeschel, V; Reimer, P; Rosenwald, A; Roussel, M; Sanhes, L; Schmitz, N; Sibon, D; Tournilhac, O; Truemper, L; Viardot, A; Wagner, E; Wilhelm, M; Wulf, G; Ziepert, M | 1 |
Altmann, B; Bentz, M; Borchmann, P; Dreyling, M; Frontzek, F; Glass, B; Haenel, M; Held, G; Horn, H; Kroschinsky, FP; Lenz, G; Loeffler, M; Metzner, B; Nickelsen, M; Ott, G; Rosenwald, A; Schmitz, N; Staiger, AM; Truemper, L; Viardot, A; Ziepert, M | 1 |
Iida, S; Inagaki, H; Ishida, T; Ito, A; Iwasaki, H; Kusumoto, S; Masaki, A; Murase, T; Muto, R; Nakano, N; Sakamoto, Y; Takeshita, M; Tashiro, Y; Tokunaga, M; Ueda, R; Utsunomiya, A; Yonekura, K | 1 |
David, R; Doherty, A; Gee, S; Khan, K; Wilson, A | 1 |
Abgral, R; Berthou, C; Guillerm, G; Ianotto, JC; LE Roux, PY; Lombion, N; Robin, P; Salaün, PY; Schick, U; Tempescul, A | 1 |
Agrawal, A; Bagal, B; Bonda, VNA; Epari, S; Goda, JS; Gujral, S; Jain, H; Jobanputra, K; Khanna, N; Laskar, S; Nayak, L; Rangarajan, V; Sengar, M; Shet, T; Thorat, J | 1 |
Barreto, GC; Brito, CV; Costa, RO; Culler, HF; Lage, LAPC; Levy, D; Pereira, J; Reichert, CO; Rocha, V; Zerbini, MCN | 1 |
Ando, J; Ando, M; Komatsu, N; Yasuda, H | 1 |
Agarwal, A; Alahari, A; Bagal, B; Gota, V; Gujral, S; Gupta, H; Jain, H; Kannan, S; Kumar, S; Laskar, SS; Menon, H; Nayak, L; Rangarajan, V; Sengar, M; Sharma, N; Shet, T; Sridhar, E; Thorat, J | 1 |
33 review(s) available for etoposide and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Histiocytic Sarcoma; Humans; Male; Prednisolone; Remission Induction; Vincristine | 1991 |
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Vincristine | 1994 |
[Chemotherapy of relapsed AML and ALL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Recurrence; Remission Induction; Vinblastine | 1996 |
[Value of radiotherapy in disseminated high-grade non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Vincristine | 1997 |
[Treatment of lymphoma in the aged].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Palliative Care; Prednimustine; Prednisolone; Prednisone; Prognosis; Vincristine | 1998 |
[A case of adult T cell leukemia (lymphoma type) involving the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Pancreatic Neoplasms; Prednisolone; Remission Induction; Vincristine | 1999 |
Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aneuploidy; Bone Marrow Transplantation; Child; Child, Preschool; Clone Cells; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Japan; Male; Prednisolone; Prognosis; Treatment Outcome | 2000 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2001 |
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma.
Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine | 2002 |
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2001 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Recurrence; Risk; Thioguanine; United Kingdom; Vincristine | 2002 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema Induratum; Erythema Nodosum; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Prednisolone; Prednisone; Pregnancy; Procarbazine; Remission Induction; Vincristine | 2003 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
Testicular granulocytic sarcoma, a source of diagnostic confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytarabine; Cytoplasmic Granules; Daunorubicin; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Sarcoma, Myeloid; Testicular Neoplasms; Vincristine | 2004 |
[Progress of the ATLL study: an overview].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Doxorubicin; Etoposide; Genes, p16; Genes, p53; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Mutation; Nitrosourea Compounds; Prednisolone; Receptors, Cytokine; Vincristine; Vindesine | 2005 |
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; Etoposide; Guanidine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Parasympathomimetics; Plasmapheresis; Potassium Channel Blockers; Prednisolone; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2006 |
Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
Topics: Adenoma, Sweat Gland; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carcinoma, Acinar Cell; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parotid Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survivors; Sweat Gland Neoplasms; Vincristine; Whole-Body Irradiation | 2008 |
[Treatment of localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Glyoxal; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Peripheral Blood Stem Cell Transplantation; Prednimustine; Prednisolone; Prognosis; Radiotherapy; Vincristine | 2008 |
Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Mantle-Cell; Male; Prednisolone; Remission Induction; Stem Cell Transplantation; Vincristine | 2009 |
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Lomustine; Palliative Care; Patient Satisfaction; Prednisolone; Survival Analysis; Survivors; Time Factors | 2010 |
[Management of diffuse large B-cell lymphoma in the rituximab era].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2009 |
Anaplastic large cell lymphoma, ALK-positive.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Prednisolone; Prednisone; Receptor Protein-Tyrosine Kinases; Stem Cell Transplantation; T-Lymphocytes; Translocation, Genetic; Vincristine | 2012 |
[Hemophagocytic lymphohistiocytosis].
Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine | 2014 |
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Cytokines; Doxorubicin; Etoposide; Humans; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Syndrome; Treatment Outcome; Vincristine | 2015 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy.
Topics: Antineoplastic Agents; Central Nervous System; Child; Clinical Trials as Topic; Drug Therapy, Combination; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Prednisolone; Thalidomide; Vinblastine | 2018 |
The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cyclophosphamide; Doxorubicin; Etoposide; Gene Dosage; Humans; Lymphoma, Large B-Cell, Diffuse; Mutation; Prednisolone; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2020 |
Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Methotrexate; Postpartum Period; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab; Vincristine | 2020 |
Diffuse Large B-cell Lymphoma of Testis: a Case Report and Current Literature Review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Orchiectomy; Prednisolone; Testicular Neoplasms; Vincristine | 2020 |
[Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Nasal Mucosa; Neoplasm Staging; Nose Neoplasms; Plasmablastic Lymphoma; Prednisolone; Remission Induction; Tomography, X-Ray Computed; Vincristine | 2020 |
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Mechlorethamine; Nivolumab; Prednisolone; Procarbazine; Renal Dialysis; Vinblastine; Vincristine; Vinorelbine | 2022 |
123 trial(s) available for etoposide and prednisolone
Article | Year |
---|---|
Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Brain; Child; Child, Preschool; Cytarabine; Doxorubicin; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Prednisolone; Survival Analysis; Vincristine | 1992 |
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone | 1992 |
'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Vincristine | 1992 |
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1992 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vincristine | 1991 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoiesis; Humans; Inflammation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucous Membrane; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1991 |
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Vincristine; Vindesine | 1990 |
[Experiences with a new second-line protocol in the treatment of pretreated and advanced Hodgkin disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction | 1990 |
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Recurrence; Remission Induction; T-Lymphocytes; Vinblastine; Vindesine | 1989 |
CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Germany, West; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prednisone; Survival Rate; Vincristine | 1989 |
Combination chemotherapy with c-DDP, cyclophosphamide, etoposide and prednisolone in small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prednisolone | 1985 |
[A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prospective Studies; Random Allocation; Remission Induction; Vincristine | 1988 |
Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Thioguanine; Vincristine | 1987 |
[Clinical study of non-Hodgkin's lymphoma--results of the Kanazawa University-Kurume University Cooperative Study on Malignant Lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisolone; Vincristine | 1986 |
[Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Leukopenia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin; Prednisolone; Thrombocytosis; Vincristine | 1984 |
ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine | 1994 |
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Risk Factors; Transplantation, Autologous; Vindesine | 1994 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; DNA Adducts; Doxorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prednisolone; Recurrence; Survival Analysis; Thioguanine; Vincristine | 1995 |
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisolone; Procarbazine; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1995 |
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Vincristine | 1993 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine | 1993 |
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Japan; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisolone; Remission Induction; Vincristine | 1995 |
[Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Prednisolone; Recurrence; Remission Induction; Survival Rate; Vincristine | 1995 |
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorubicin; Etoposide; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Libido; Luteinizing Hormone; Male; Mechlorethamine; Menstrual Cycle; Middle Aged; Prednisolone; Primary Ovarian Insufficiency; Procarbazine; Prospective Studies; Semen; Sex Hormone-Binding Globulin; Sperm Count; Testis; Testosterone; Vinblastine; Vincristine | 1995 |
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fertility; Follow-Up Studies; Gonadotropins; Gonads; Hodgkin Disease; Humans; Male; Prednisolone; Sperm Count; Stroke Volume; Time Factors; Vincristine | 1995 |
A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine | 1994 |
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine; Vindesine | 1994 |
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Prednisone; Procarbazine; Remission Induction; Treatment Failure; Vinblastine; Vincristine | 1994 |
NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Heart Failure; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednisolone; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
[A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction | 1994 |
EPIC: an effective low toxicity regimen for relapsing lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone | 1993 |
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine | 1993 |
The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prognosis; Survival Rate; Transplantation, Autologous; Vincristine | 1996 |
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
[Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Prednisolone; Procarbazine; Remission Induction; Vincristine; Vindesine | 1996 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1996 |
[An intensive chemotherapy of adult T-cell leukemia/lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Prednisolone; Proportional Hazards Models; Remission Induction; Survival Rate; Vincristine; Vindesine | 1996 |
[Treatment results for unselected patients with acute myelogenous leukemia. During a 10-year period, August 1984 to July 1994].
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Patient Selection; Prednisolone; Remission Induction; Retrospective Studies; Treatment Outcome | 1996 |
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fertility; Follow-Up Studies; Hematologic Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Retreatment; Treatment Outcome; Vincristine | 1997 |
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Survival Rate; Vincristine; Vindesine | 1997 |
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine | 1997 |
Weekly chemotherapy using PMitCEBO in the palliation of recurrent non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Palliative Care; Prednisolone; Recurrence; Vincristine | 1997 |
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Prednisolone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Thioguanine; Vincristine | 1998 |
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group.
Topics: Aclarubicin; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Vincristine | 1998 |
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prospective Studies; Survival Rate; United Kingdom; Vincristine | 1998 |
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carmustine; Cell Separation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Macrophages; Male; Melphalan; Neoplasms; Prednisolone; Vincristine | 1998 |
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Treatment Outcome; Vincristine | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence | 1999 |
High incidence of treatment failure with vincristine, etoposide, epirubicin, and prednisolone chemotherapy with successful salvage in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Prospective Studies; Salvage Therapy; Treatment Failure; Vincristine | 1999 |
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitoguazone; Outcome Assessment, Health Care; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Vinblastine; Vincristine | 1999 |
Telomerase activity in central nervous system malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Catalytic Domain; Combined Modality Therapy; DNA-Binding Proteins; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Survival Analysis; Telomerase; Vincristine | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine | 1999 |
Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Interleukin-3; Methotrexate; Methylprednisolone; Neutropenia; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 2000 |
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 1999 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Severity of Illness Index; Survival Analysis; United Kingdom; Vincristine | 2000 |
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; DNA Mutational Analysis; Etoposide; Female; Gene Deletion; Genes, p53; Humans; Japan; Leukemia, Myeloid; Life Tables; Male; Mercaptopurine; Middle Aged; Mutation; Mutation, Missense; Neoplasm Proteins; Prednisolone; Prognosis; Regulatory Sequences, Nucleic Acid; Single-Blind Method; Survival Analysis; Tumor Suppressor Protein p53; Vincristine | 2000 |
CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study. The Adult Lymphoma Treatment Study Gr
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Prednisolone; Prognosis; Remission Induction; Risk Factors; Treatment Outcome; Vincristine | 2000 |
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine | 2001 |
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 2001 |
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine | 2001 |
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Metaphase; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prednisolone; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2001 |
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Germany; Humans; Life Tables; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Follow-Up Studies; Gene Deletion; Genotype; Glutathione Transferase; Humans; Isoenzymes; Leukemia, Myeloid; Mercaptopurine; Multivariate Analysis; NAD(P)H Dehydrogenase (Quinone); Neoplasm Proteins; Peroxidase; Polymorphism, Genetic; Prednisolone; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome | 2002 |
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Survival Rate; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2000 |
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Italy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Procarbazine; Prognosis; Treatment Outcome; United Kingdom; Vinblastine; Vincristine | 2002 |
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Germany; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2002 |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Epirubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Risk Factors; Survival Analysis; Treatment Outcome; Virus Activation | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 2003 |
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine | 2005 |
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Procarbazine; Treatment Outcome; Vincristine; Vindesine | 2006 |
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Pulse Therapy, Drug; Remission Induction; Risk; Survival Rate; Treatment Outcome; Vincristine | 2005 |
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Remission Induction; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2006 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Surveys; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Risk Factors; Survival Rate; Vincristine | 2007 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Germany; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2007 |
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Software; Vincristine | 2008 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome; Vincristine | 2008 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Erythrocyte Transfusion; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Platelet Transfusion; Prednisolone; Remission Induction; Vincristine | 2008 |
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Vincristine | 2008 |
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prednisolone; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Prednisolone; Prognosis; Recombinant Proteins; Rituximab; Survival Analysis; Treatment Outcome | 2008 |
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 2009 |
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Radiotherapy Dosage; Survival Rate; Time Factors | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Mesna; Middle Aged; Mitoxantrone; Peripheral Nervous System Diseases; Prednisolone; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Treatment Outcome; Vincristine | 2010 |
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Survival Rate; Vincristine; Vomiting; Young Adult | 2009 |
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult | 2010 |
Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Recurrence; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vincristine; Young Adult | 2010 |
Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2010 |
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Prednisolone; Prednisone; Proportional Hazards Models; Prospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Doxorubicin; Epidemiologic Methods; Etoposide; Female; Hematologic Diseases; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Proteins; NM23 Nucleoside Diphosphate Kinases; Prednisolone; Prognosis; Treatment Outcome; Vincristine; Young Adult | 2011 |
Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Prednisolone; Vincristine | 2012 |
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Rituximab; Sirolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Vincristine; Young Adult | 2012 |
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Vincristine; Young Adult | 2012 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisolone; Republic of Korea; Treatment Outcome; Young Adult | 2014 |
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Hydroxamic Acids; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Palliative Care; Prednisolone; Recurrence; Rituximab; Stem Cell Transplantation; Survival Rate; Vorinostat | 2015 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vincristine; Vindesine | 2015 |
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine | 2015 |
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisolone; Prednisone; Prognosis; Protein Array Analysis; Proteomics; Risk Factors; Rituximab; Survival Analysis; Vincristine; Young Adult | 2016 |
Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Retrospective Studies; Risk Factors; Vinblastine; Vincristine | 2018 |
Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Risk Factors; Survival Rate; Vincristine | 2018 |
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Methotrexate; Prednisolone; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2019 |
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Vincristine | 2019 |
Efficacy and Safety of Metronomic Chemotherapy Versus Palliative Hydroxyurea in Unfit Acute Myeloid Leukemia Patients: A Multicenter, Open-Label Randomized Controlled Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Prognosis; Survival Rate | 2020 |
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Topics: Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Myeloablative Agonists; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prospective Studies; Risk; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2021 |
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Intention to Treat Analysis; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Progression-Free Survival; Rituximab; Safety; Topoisomerase II Inhibitors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2021 |
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prednisone; Vinblastine; Vincristine | 2023 |
265 other study(ies) available for etoposide and prednisolone
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The distinctive features of acute monocytic leukemia.
Topics: Blood Coagulation Disorders; Cell Nucleus; Disseminated Intravascular Coagulation; Esterases; Etoposide; Gingival Hypertrophy; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lymph Nodes; Monocytes; Muramidase; Prednisolone; Vinblastine; Vincristine | 1978 |
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1992 |
Tryptophan and serotonin metabolism in familial erythrophagocytic lymphohistiocytosis.
Topics: Aging; Amino Acids; Biopterins; Child, Preschool; Etoposide; Histiocytosis, Non-Langerhans-Cell; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Male; Methotrexate; Neopterin; Prednisolone; Serotonin; Tryptophan | 1992 |
Cisplatin therapy in infants: short and long-term morbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chlorambucil; Cisplatin; Electrolytes; Etoposide; Female; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Morbidity; Neuroblastoma; Prednisolone; Seizures; Teratoma; Time Factors; Vincristine | 1992 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins | 1992 |
[The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis].
Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Atherectomy; Cell Division; Cells, Cultured; Colchicine; Dipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Etoposide; Humans; Lisinopril; Muscle, Smooth, Vascular; Prednisolone; Propranolol; Recurrence; Vincristine | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Prednisolone | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1992 |
[Recent progress in the chemotherapy program and its theoretical background--malignant lymphoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Prednisolone; Survival Rate; Vincristine | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vincristine | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Remission Induction; Vincristine | 1992 |
[Immunoblastic lymphadenopathy-like T cell lymphoma accompanied by autoimmune hemolytic anemia].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Remission Induction | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine | 1992 |
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction | 1992 |
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Vincristine | 1990 |
[Cell culture as a prescreening system for drug prevention of restenosis?].
Topics: Angioplasty, Balloon; Arteriosclerosis; Cell Division; Cells, Cultured; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Humans; Muscle, Smooth, Vascular; Prednisolone; Premedication; Propranolol | 1991 |
Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisolone; Recurrence; Remission Induction; Survival Rate; Vincristine | 1991 |
Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Congenital Hypothyroidism; Cranial Irradiation; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hypothyroidism; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Translocation, Genetic; Vincristine | 1990 |
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisolone; Remission Induction | 1990 |
[Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy].
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Survival Rate; Vindesine | 1990 |
Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management.
Topics: Biopterins; Central Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Macrophage Activation; Methotrexate; Neopterin; Prednisolone; Virus Diseases | 1990 |
The treatment of advanced seminoma with chemotherapy and radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dysgerminoma; Etoposide; Humans; Male; Middle Aged; Prednisolone; Prognosis; Testicular Neoplasms; Vinblastine; Vindesine | 1988 |
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Remission Induction; Vindesine | 1989 |
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Prednisolone; Procarbazine | 1989 |
Onycholysis associated with cytotoxic drugs.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Nail Diseases; Prednisolone; Vincristine | 1985 |
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Time Factors | 1989 |
[Chemotherapy of adult ANLL].
Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Survival Rate; Vincristine | 1989 |
[Relapse of gingival tumor during hematological remission in acute promyelocytic leukemia].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Gingival Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Recurrence; Remission Induction; Vinblastine; Vincristine | 1989 |
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Vincristine | 1989 |
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Time Factors; Vincristine | 1989 |
The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
Topics: Adolescent; Arginine Vasopressin; Blepharoptosis; Child; Child, Preschool; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Pituitary Gland, Posterior; Prednisolone; Prospective Studies; Time Factors | 1989 |
[A case of chronic adult T-cell leukemia benefited by small doses of MEPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Leukemia, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone; Skin | 1988 |
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1988 |
Effect of monocytopenia on trauma-induced atherosclerotic lesions in the rabbit ear artery.
Topics: Animals; Arteries; Arteriosclerosis; Disease Models, Animal; Etoposide; Female; Hematocrit; Leukocyte Count; Leukopenia; Monocytes; Prednisolone; Rabbits | 1988 |
[Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
Topics: Aclarubicin; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes; Prednisolone; Sex Factors; Vincristine | 1987 |
Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone | 1987 |
[A case of coexisting primary malignant lymphoma and adenocarcinoma of the stomach].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrectomy; Gastroscopy; Humans; Lymphoma; Neoplasms, Multiple Primary; Prednisolone; Stomach; Stomach Neoplasms; Vinblastine; Vincristine | 1986 |
[Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Vincristine | 1986 |
[Salvage chemotherapy of non-Hodgkin's lymphoma with a four-drug combination of mitoxantrone, etoposide, cisplatin and prednisolone (MEPP)].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone | 1987 |
[VP 16-213].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma; Methotrexate; Podophyllotoxin; Prednisolone | 1985 |
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Topics: Acyclovir; Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Herpes Genitalis; HLA Antigens; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Nystatin; Prednisolone; Tissue Donors; Whole-Body Irradiation | 1985 |
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine | 1986 |
Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Vinblastine; Vindesine | 1985 |
[Mitoxantrone in the treatment of relapsed and refractory malignant lymphoma].
Topics: Adult; Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Mitoxantrone; Prednisolone; Recurrence | 1985 |
Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Prednisolone; Skin Neoplasms; Vincristine | 1980 |
Prospective study of follow up alone in stage I teratoma of the testis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Prednisolone; Prospective Studies; Teratoma; Testicular Neoplasms; Vinblastine; Vindesine | 1983 |
Ultraviolet recall associated with etoposide and cyclophosphamide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Eruptions; Etoposide; Humans; Leucovorin; Male; Methotrexate; Prednisolone; Recurrence; Sunburn; Vincristine | 1993 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1994 |
Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, AIDS-Related; Melphalan; Prednisolone; Vincristine | 1994 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine | 1994 |
[Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Killer Cells, Natural; Leukemia, Myeloid, Acute; Melphalan; Multiple Myeloma; Neoplasms, Second Primary; Prednisolone | 1995 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Salvage Therapy; Vincristine | 1995 |
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine | 1995 |
Predicting neutropenia after chemotherapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lymphoma; Male; Mechlorethamine; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisolone; Procarbazine; Retrospective Studies; Risk Factors; Thrombocytopenia; Vinblastine; Vincristine | 1993 |
Hepatitis after withdrawal of chemotherapy in a patient with chronic hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hepatitis B; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Prednisolone; Vincristine | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1993 |
Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Vincristine | 1993 |
Cutaneous T-cell lymphoma presenting as facial swelling: report of a case and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cheek; Cyclophosphamide; Etoposide; Facial Neoplasms; Forearm; Humans; Lomustine; Lymphoma, T-Cell, Cutaneous; Male; Prednisolone; Skin Neoplasms | 1994 |
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Etoposide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Mechlorethamine; Middle Aged; Prednisolone; Procarbazine; Sex Hormone-Binding Globulin; Testosterone; Vinblastine | 1994 |
[Cytological features and prognosis of megakaryoblastic leukemia].
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Histocytochemistry; Humans; Infant; Male; Methotrexate; Microscopy, Electron; Middle Aged; Nitrosourea Compounds; Peroxidase; Prednisolone; Prognosis; Thrombocythemia, Essential; Vincristine | 1994 |
[Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Immunoglobulin kappa-Chains; Immunoglobulin Light Chains; Interferon-alpha; Leukemia, Plasma Cell; Male; Prednisolone; Vindesine | 1994 |
CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine | 1993 |
Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo.
Topics: Adolescent; Apoptosis; Child; Child, Preschool; DNA Damage; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured | 1994 |
Hemolytic uremic syndrome developing during remission of acute myelomonocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Hemolytic-Uremic Syndrome; Humans; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Plasma Exchange; Platelet Aggregation Inhibitors; Prednisolone; Remission Induction; Zinostatin | 1993 |
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia.
Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Child; Child, Preschool; Chlorhexidine; Colony Count, Microbial; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mouth; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Streptococcus mutans; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1993 |
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Prospective Studies; Thioguanine | 1993 |
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Drug Hypersensitivity; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Vincristine | 1993 |
Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
Topics: Afibrinogenemia; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Prednisolone; Radiography | 1993 |
[A case of mycosis fungoides with pulmonary involvement: effect of etoposide and prednisolone].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lung Neoplasms; Male; Mycosis Fungoides; Neoplasm Invasiveness; Prednisolone; Skin Neoplasms | 1995 |
Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia.
Topics: Aclarubicin; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 9; Codon; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Genes, ras; Genetic Vectors; Humans; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Point Mutation; Prednisolone; Vinblastine; Vincristine | 1995 |
Oral low-dose etoposide therapy for refractory multiple myeloma with extramedullary involvement.
Topics: Administration, Oral; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Male; Multiple Myeloma; Prednisolone; Procarbazine; Remission Induction | 1995 |
Interleukin-2 therapy of Langerhans cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Interleukin-2; Killer Cells, Natural; Prednisolone; Receptors, IgG; Remission Induction; Vindesine | 1995 |
Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin's lymphoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Intestinal Neoplasms; Kidney Diseases; Leukocytosis; Lymphoma, Large B-Cell, Diffuse; Male; Neutropenia; Prednisolone; Recombinant Proteins; Remission Induction; Vinca Alkaloids | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine | 1996 |
[CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, CD7; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Etoposide; Gene Rearrangement; HLA-DR Antigens; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Leukemia; Membrane Glycoproteins; Mitoxantrone; N-Glycosyl Hydrolases; Prednisolone; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Skin Neoplasms; Thymoma; Thymus Neoplasms | 1996 |
[Chemotherapy for two patients with non-Hodgkin's lymphoma in hemodialysis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Kidney Failure, Chronic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Remission Induction; Renal Dialysis; Vincristine | 1996 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
What is the best method of prevention of therapeutic failures in CNS in high risk retinoblastoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child, Preschool; Chlorambucil; Etoposide; Humans; Male; Orbital Neoplasms; Prednisolone; Retinoblastoma; Risk Factors; Vincristine | 1997 |
Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocortisone; Leydig Cells; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sertoli Cells; Spermatogonia; Testis | 1996 |
[The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Mitoxantrone; Neoplasm, Residual; Oncogene Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prednisolone; Recombinant Fusion Proteins; RNA, Messenger; Translocation, Genetic | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone | 1997 |
Salvage treatment after failure or relapse following initial chemotherapy for follicular non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Life Tables; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Remission Induction; Salvage Therapy; Survival Analysis; Vincristine | 1997 |
Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Cell Division; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Drug Interactions; Etoposide; Female; Male; Prednisolone; Rats; Tibia | 1998 |
Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Cells, Cultured; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Etoposide; Growth Plate; Male; Mercaptopurine; Methotrexate; Prednisolone; Rats; Rats, Sprague-Dawley; Thioguanine | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Prednisolone; Pulmonary Fibrosis; Vascular Neoplasms; Vincristine | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 1998 |
Functional imaging of Hodgkin's disease with FDG-PET and gallium-67.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium Radioisotopes; Glucose; Hodgkin Disease; Humans; Lymph Nodes; Male; Middle Aged; Prednisolone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 1998 |
Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Herpesviridae Infections; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Karyotyping; Longitudinal Studies; Male; Prednisolone; RNA, Viral; Treatment Outcome | 1998 |
Six-year survival after excision of cardiac malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Neoplasms; Humans; Leukemia-Lymphoma, Adult T-Cell; Pentostatin; Prednisolone; Vincristine | 1998 |
Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.
Topics: Child; Child, Preschool; Cyclosporine; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Glucocorticoids; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Male; Prednisolone; Remission Induction; Steroids | 1999 |
A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Recurrence; Salvage Therapy; Vincristine | 1998 |
CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD4 Antigens; CD8 Antigens; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Enterocolitis; Etoposide; Gastritis; Hepatomegaly; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplastic Stem Cells; Nitrosourea Compounds; Prednisolone; T-Lymphocyte Subsets; Vincristine; Vindesine | 1999 |
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine | 1999 |
Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, myc; Humans; Immunophenotyping; Karyotyping; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Translocation, Genetic; Vincristine | 1999 |
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Female; Gallium; Gallium Radioisotopes; Humans; Ifosfamide; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Radiopharmaceuticals; Remission Induction; Technetium; Thallium; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1999 |
A case of hemophagocytic lymphohistiocytosis with prolonged remission after syngeneic bone marrow transplantation.
Topics: Bone Marrow Cells; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; gamma-Globulins; Granulocyte Colony-Stimulating Factor; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Lymphocytes; Prednisolone; Recombinant Proteins; Transplantation, Isogeneic; Twins, Dizygotic | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Topics: Alendronate; Animals; Apoptosis; Calcitonin; Cell Line; Cells, Cultured; Dexamethasone; Diphosphonates; Etidronic Acid; Etoposide; In Situ Nick-End Labeling; Mice; Osteoblasts; Osteocytes; Pamidronate; Prednisolone; Skull; Tumor Necrosis Factor-alpha | 1999 |
Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymph
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisolone; Quality of Life; Survival Rate | 1999 |
Class I histiocytosis: response to combination of etoposide and prednisolone.
Topics: Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Infant; Injections, Intravenous; Male; Nucleic Acid Synthesis Inhibitors; Prednisolone; Remission Induction | 1999 |
[Bronchiolitis obliterans with organizing pneumonia secondary to chemotherapy in a child with primary pericardial sarcoma].
Topics: Antineoplastic Agents; Biopsy; Child, Preschool; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Doxorubicin; Etoposide; Heart Neoplasms; Humans; Male; Pericardium; Prednisolone; Sarcoma; Tomography, X-Ray Computed; Vincristine | 2000 |
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Blotting, Southern; Brain Neoplasms; Cell Division; Cell Transformation, Viral; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; In Situ Hybridization; Interferon-gamma; Interleukin-10; Karyotyping; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Male; Polymerase Chain Reaction; Prednisolone; Receptors, Interleukin-2; T-Lymphocytes; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Vincristine | 2000 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine | 2000 |
Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Division; Cyclohexanes; Endothelium, Vascular; Etoposide; Hemangiosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; O-(Chloroacetylcarbamoyl)fumagillol; Prednisolone; Reference Values; Sesquiterpenes; Skin Neoplasms; Tumor Cells, Cultured | 2000 |
Chemotherapy and marrow transplantation for congenital leukaemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Infant, Newborn; Leukemia; Methotrexate; Mitoxantrone; Prednisolone; Treatment Outcome; Vincristine | 2001 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting | 2001 |
Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Transfusion; Combined Modality Therapy; Disease Progression; Etoposide; Fatal Outcome; Female; Fluid Therapy; Hemofiltration; Histiocytosis, Langerhans-Cell; Humans; Infant; L-Lactate Dehydrogenase; Lymph Nodes; Mercaptopurine; Multiple Organ Failure; Neck; Orbital Diseases; Prednisolone; Sodium Bicarbonate; Temporal Bone; Tumor Lysis Syndrome; Uric Acid; Vinblastine; Vincristine | 2001 |
Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Etoposide; Female; Humans; Prednisolone; Procarbazine; Vincristine | 2000 |
[High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Remission Induction; Treatment Outcome; Vincristine | 2001 |
Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Fatal Outcome; Female; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunity, Cellular; Immunocompromised Host; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Follicular; Magnetic Resonance Imaging; Mitoxantrone; Nitrosourea Compounds; Papillomavirus Infections; Piperazines; Polymerase Chain Reaction; Prednisolone; Recurrence; Salvage Therapy; Vincristine; Vindesine; Virus Activation | 2001 |
Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Immunocompromised Host; Male; Methotrexate; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Respiratory Insufficiency; Transplantation Conditioning; Transplantation, Autologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Whole-Body Irradiation | 2001 |
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Topics: Amsacrine; Anthracyclines; Antineoplastic Agents; Busulfan; Cell Survival; Child; Child, Preschool; Cytarabine; Down Syndrome; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Thioguanine; Vincristine | 2002 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Vincristine | 2001 |
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Chromosomes, Human, Pair 3; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Genes, bcl-2; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Point Mutation; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Transcription Factors; Treatment Outcome; Vincristine | 2002 |
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Piperazines; Prednisolone; Remission Induction; Tretinoin; Vincristine | 2002 |
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Prednisolone; Prednisone; Rituximab; Sarcoidosis; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2002 |
Cure in a case of primary hepatic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lymphoma; Male; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine | 2000 |
Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Neoplasms, Second Primary; Nuclear Pore Complex Proteins; Prednisolone; Topoisomerase II Inhibitors; Translocation, Genetic; Vinblastine | 2002 |
[Effectiveness of prolonged oral administration of low-dose etoposide in a case of malignant lymphoma in the mesenterium].
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Follicular; Mesentery; Peritoneal Neoplasms; Prednisolone; Vincristine | 2002 |
Lymphoma in an ileostomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ileal Neoplasms; Ileostomy; Lymphoma, B-Cell; Male; Prednisolone; Vincristine | 2002 |
Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Vinblastine | 2002 |
Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Germany; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Prednisolone; Randomized Controlled Trials as Topic; Risk; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2002 |
Coeliac disease following high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Diarrhea; Diet; Doxorubicin; Etoposide; Glutens; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Morbidity; Prednisolone; Vincristine | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
When lymphoma and heart failure cross paths.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Etoposide; Female; Heart Neoplasms; Humans; Lymphoma; Prednisolone; Prednisone; Treatment Outcome; Vincristine | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
[Severe type of Epstein-Barr virus associated hemophagocytic syndrome successfully treated with T-COP-E and splenectomy].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Prednisolone; Splenectomy; Vincristine | 2003 |
Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Interleukin 1 Receptor Antagonist Protein; Male; Predictive Value of Tests; Prednisolone; Receptors, Interleukin-1; Recombinant Proteins; Sialoglycoproteins; Tumor Necrosis Factor-alpha; Vinblastine | 2003 |
Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interprofessional Relations; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Neoplasms, Multiple Primary; Patient Care Team; Polymerase Chain Reaction; Prednisolone; Prednisone; Treatment Outcome; Vincristine; Vindesine | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
[Focal concentrations in the hepatic CT in superior vena cava thrombosis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, B-Cell; Prednisolone; Rituximab; Superior Vena Cava Syndrome; Time Factors; Tomography, X-Ray Computed; Vincristine | 2003 |
Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chest Pain; Combined Modality Therapy; Cough; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Transplantation, Autologous; Vincristine | 2003 |
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Irinotecan; L-Lactate Dehydrogenase; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine | 2004 |
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell; Male; Mitoxantrone; Nasal Cavity; Nose Neoplasms; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Salvage Therapy; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine | 2004 |
[Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Extremities; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Osteolysis; Prednisolone; Vincristine; Vindesine | 2004 |
Teaching cases from the Royal Marsden and St Mary's Hospitals, case 26: refractory microcytic anaemia.
Topics: Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Sedimentation; C-Reactive Protein; Chlorambucil; Cough; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Inflammation; Male; Middle Aged; Prednisolone; Procarbazine; Remission Induction; Splenomegaly; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2004 |
[Pathophysiology of and therapy for hemophagocytic syndrome].
Topics: Cyclosporine; Cytokines; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Macrophages; Plasma Exchange; Prednisolone; Prognosis; T-Lymphocytes | 2004 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisolone; Rituximab; Treatment Outcome; Vincristine | 2005 |
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Melphalan; Middle Aged; Prednisolone; Prognosis; Recurrence; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2005 |
[Mediastinal large B-cell lymphoma with symptomatic superior vena cava syndrome in a patient with bichorial twin pregnancy in the 26th week of gestation: peri-and postpartal management -- a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Lymphoma, B-Cell; Magnetic Resonance Imaging; Parity; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Superior Vena Cava Syndrome; Treatment Outcome; Vincristine | 2005 |
[Tandem autotransplants of peripheral blood stem cells following sequential high-dose CHOEP chemotherapy for aggressive lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 2005 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Survival Analysis; Thioguanine; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vincristine | 2007 |
[Therapy-related acute promyelocytic leukemia with a t(9;22)(q34;q11) and t(15;17)(q22;q11 to approximately 12) subclone].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Prednisolone; Remission Induction; Translocation, Genetic; Tretinoin; Vincristine | 2005 |
Thalidomide for the treatment of leptomeningeal multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunoglobulin G; Melphalan; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Thalidomide; Vindesine | 2006 |
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Retrospective Studies; Rituximab; Vincristine | 2006 |
[Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Asparagine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured; Vincristine | 2005 |
Recurrent thrombophlebitis in association with CHOEP-14.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Middle Aged; Prednisolone; Recurrence; Thrombophlebitis; Time Factors; Vincristine | 2006 |
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Time Factors; Treatment Outcome | 2006 |
[Twenty years of treating childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Recurrence; Risk Factors; Survival Rate; Time Factors; Vincristine | 2006 |
[Prolonged remission after immunotherapy of a previously refractory peripheral T-cell non-Hodgkin lymphoma].
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; L-Lactate Dehydrogenase; Lymphoma, T-Cell, Peripheral; Middle Aged; Neoplasm Staging; Prednisolone; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein-Barr virus reactivation.
Topics: Aged; Antiviral Agents; Blood Transfusion; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Glucocorticoids; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Polyarteritis Nodosa; Prednisolone | 2006 |
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymph Nodes; Lymphoma, T-Cell; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion, Malignant; Prednisolone; Tuberculosis, Pleural; Vincristine | 2006 |
Early-onset sarcoidosis mimicking refractory cutaneous histiocytosis.
Topics: Child; Diagnosis, Differential; Diagnostic Errors; Early Diagnosis; Etoposide; Facial Dermatoses; Female; Histiocytosis; Humans; Hypercalcemia; Interferon-gamma; Interleukins; Macrophage Activation; Methotrexate; Prednisolone; Sarcoidosis; Skin Diseases; Vinblastine | 2008 |
[Chemotherapy of BOVAPEC in the primary treatment of Hodgkin's lymphoma intermediate stages].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Vinblastine; Vincristine | 2007 |
Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclins; Cyclophosphamide; Doxorubicin; Drug Synergism; Etoposide; Gossypol; Humans; Lymphoma, Non-Hodgkin; Paclitaxel; Prednisolone; Tumor Suppressor Protein p53; Vincristine | 2008 |
Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cellular Senescence; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cells; Humans; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Myelopoiesis; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prospective Studies; Rituximab; Telomere; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2008 |
[A short duration treatment with intensive consolidation therapy for patients with acute myelogenous leukemia--13 year experience in a single institute].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Evidence-Based Medicine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Quality of Life; Retrospective Studies; Survival Rate; Vincristine | 2007 |
[Case of malignant lymphoma associated with rheumatoid arthritis].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphoma, B-Cell; Mediastinum; Methotrexate; Prednisolone; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2008 |
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 2008 |
[Case of cancer-associated retinopathy in which immediate treatment succeeded].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Methylprednisolone; Paraneoplastic Syndromes; Prednisolone; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome | 2008 |
Clinical investigations in aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednisolone; Prednisone; Rituximab; Vincristine | 2008 |
Folliculotropic mycosis fungoides and a leonine clinical appearance of the face.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Cyclophosphamide; Doxorubicin; Etoposide; Facial Neoplasms; Hair Follicle; Humans; Interferon-alpha; Male; Mycosis Fungoides; Prednisolone; Prednisone; PUVA Therapy; Skin Neoplasms; Vincristine | 2008 |
Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carmustine; Cisplatin; Colitis; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Intestinal Pseudo-Obstruction; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Postoperative Complications; Prednisolone; Rituximab; Transplantation, Autologous; Vincristine; Virus Activation | 2009 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germinal Center; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Rituximab; Survival Rate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Vincristine; Young Adult | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine | 2010 |
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; NADPH Oxidases; Polymorphism, Single Nucleotide; Prednisolone; Protein Subunits; RNA, Messenger; Treatment Outcome; Vincristine; Young Adult | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Analysis; Tunisia; Vincristine; Young Adult | 2010 |
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisolone; Remission Induction; Sirolimus; Tongue Neoplasms; Treatment Failure; Treatment Outcome; Vincristine | 2011 |
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisolone; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; NM23 Nucleoside Diphosphate Kinases; Prednisolone; Prognosis; Rituximab; Vincristine; Young Adult | 2011 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD56 Antigen; Chromosomes, Human, Pair 11; Cyclophosphamide; Dendritic Cells; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Male; Neoplasm Recurrence, Local; Prednisolone; Skin; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Enteropathy-associated T-cell lymphoma in small intestine detected by capsule endoscopy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capsule Endoscopy; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Enteropathy-Associated T-Cell Lymphoma; Etoposide; Humans; Intestine, Small; Lymph Nodes; Male; Medical Oncology; Prednisolone; Prednisone; Remission Induction; Salvage Therapy; Vincristine | 2012 |
[22-year-old man with T-cell-lymphoma and new skin lesions].
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema; Etoposide; Hot Temperature; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Prednisolone; Receptor Protein-Tyrosine Kinases; Skin Neoplasms; Vincristine; Young Adult | 2012 |
Adult T-cell leukemia-lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2012 |
Optic glioma in children: a retrospective analysis of 101 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Optic Nerve Glioma; Prednisolone; Procarbazine; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Vincristine | 2013 |
Esophageal lesions in myeloproliferative neoplasms.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Myeloproliferative Disorders; Prednisolone; Ulcer | 2012 |
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Combined Modality Therapy; Critical Illness; Cyclosporine; Dexamethasone; Etoposide; Female; Ferritins; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Multiple Organ Failure; Plasma Exchange; Prednisolone; Regression Analysis; Sepsis; Survival Rate; Treatment Outcome; Turkey | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Leukopenia; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prednisolone; Proportional Hazards Models; Retrospective Studies; Skin; Ultraviolet Therapy; Vomiting | 2013 |
Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclosporine; Disseminated Intravascular Coagulation; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Interferon-gamma; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Plasma Exchange; Prednisolone; Tumor Necrosis Factor-alpha | 2012 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Male; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Vincristine | 2012 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Cerebellum; Child; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Guillain-Barre Syndrome; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methotrexate; Necrosis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Seizures; Spinal Cord | 2013 |
Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis?
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Drug Therapy, Combination; Etoposide; Humans; Immunologic Factors; Immunosuppressive Agents; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Middle Aged; Prednisolone; Rituximab; Time Factors | 2013 |
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Failure; Vincristine | 2013 |
[Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Eruptions; Drug Substitution; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prednisolone; Testicular Neoplasms | 2014 |
CHOEP-21 chemotherapy for newly diagnosed nodal peripheral T-cell lymphomas (PTCLs) in Maharaj Nakorn Chiang Mai Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prospective Studies; Thailand; Treatment Outcome; Vincristine; Young Adult | 2013 |
T-cell chimerism is valuable in predicting early mortality in steroid-resistant acute graft-versus-host disease after myeloablative allogeneic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Allografts; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Male; Middle Aged; Myeloablative Agonists; Organophosphorus Compounds; Prednisolone; T-Lymphocyte Subsets; Transplantation Chimera; Transplantation Conditioning; Whole-Body Irradiation; Young Adult | 2014 |
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evidence-Based Medicine; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Practice Guidelines as Topic; Prednisolone; Prednisone; Vincristine | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine | 2014 |
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Registries; Survival Analysis; Sweden; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2014 |
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisolone; Prognosis; Retrospective Studies; Young Adult | 2015 |
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autistic Disorder; Carboplatin; Cell Differentiation; Cell Line; Cell Proliferation; Cells, Cultured; Child; Disease Models, Animal; Embryo, Mammalian; Etoposide; Gene Expression Regulation; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitoxantrone; Mutation; Neurons; Prednisolone; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel | 2015 |
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.
Topics: Aneuploidy; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 20; Cyclophosphamide; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; Gene Dosage; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Prednisolone; Prednisone; Recurrence; Rituximab; Topoisomerase II Inhibitors; Vincristine | 2015 |
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Recurrence; Registries; Sweden; Vincristine | 2015 |
Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Topics: Age of Onset; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Granzymes; Herpesvirus 4, Human; Humans; Infant; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Male; Otitis; Perforin; Poly(A)-Binding Proteins; Prednisolone; Remission Induction; T-Cell Intracellular Antigen-1; T-Lymphocytes, Cytotoxic; Vincristine | 2015 |
Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Prednisone; Registries; Rituximab; Vincristine | 2017 |
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Mouth Neoplasms; Mycosis Fungoides; Prednisolone; Skin Neoplasms; Treatment Outcome; Vincristine | 2016 |
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Approval; Etoposide; Europe; Humans; International Cooperation; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Medical Oncology; Neoplasm Recurrence, Local; Oligopeptides; Prednisolone; Prognosis; Recurrence; Remission Induction; Risk; Treatment Outcome; United States; United States Food and Drug Administration; Vincristine | 2015 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine | 2016 |
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Topics: Antiviral Agents; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Ganciclovir; Herpesvirus 8, Human; Humans; Male; Middle Aged; Prednisolone; Rituximab; Valganciclovir; Vincristine | 2016 |
[Acute intestinal obstruction revealing enteropathy associated t-cell lymphoma, about a case].
Topics: Abdominal Pain; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Cyclophosphamide; Diet, Gluten-Free; Doxorubicin; Enteropathy-Associated T-Cell Lymphoma; Etoposide; Female; Humans; Intestinal Obstruction; Prednisolone; Vincristine | 2016 |
Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Bone Marrow; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Positron Emission Tomography Computed Tomography; Prednisolone; Procarbazine; Treatment Outcome | 2017 |
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermatitis, Exfoliative; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphadenopathy; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Organoplatinum Compounds; Prednisolone; Prednisone; Sezary Syndrome; Vincristine | 2017 |
Secondary CNS involvement of ALK-negative anaplastic large cell lymphoma.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Prednisolone; Receptor Protein-Tyrosine Kinases; Vincristine | 2017 |
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Denmark; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Prednisolone; Prognosis; Receptor Protein-Tyrosine Kinases; Registries; Risk Factors; Sweden; Treatment Outcome; Vincristine; Young Adult | 2017 |
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisolone; Prognosis; T-Cell Antigen Receptor Specificity; T-Lymphocytes, Cytotoxic; Vincristine | 2017 |
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Escherichia coli; Etoposide; Female; Humans; Ifosfamide; Length of Stay; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Prednisolone; Treatment Outcome | 2018 |
A rare case of Hodgkin's lymphoma presenting with papulonecrotic tuberculid.
Topics: Aged; Antineoplastic Agents; Biopsy; Cyclophosphamide; Diagnosis, Differential; Etoposide; Glucocorticoids; Hodgkin Disease; Humans; Male; Prednisolone; Procarbazine; Skin; Tuberculosis, Cutaneous | 2017 |
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Ifosfamide; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Nephrosis, Lipoid; Nephrotic Syndrome; Panniculitis; Paraneoplastic Syndromes; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 2017 |
Chronic active Epstein-Barr virus infection with cutaneous lymphoproliferation: haemophagocytosis in the skin and haemophagocytic syndrome.
Topics: Adolescent; Adult; Chronic Disease; Cyclophosphamide; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Lymphohistiocytosis, Hemophagocytic; Male; Prednisolone; Skin Diseases | 2018 |
Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.
Topics: Calcineurin Inhibitors; Dermatomyositis; Drug Therapy, Combination; Etoposide; Female; Glucocorticoids; Heart Failure; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infliximab; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Myocarditis; Prednisolone; Recurrence | 2017 |
Etoposide and Corticosteroid Combination Therapy Improves Acute Respiratory Distress Syndrome in Mice.
Topics: Animals; Disease Models, Animal; Drug Combinations; Etoposide; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Prednisolone; Respiratory Distress Syndrome | 2019 |
How I treat breast implant-associated anaplastic large cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Implantation; Breast Implants; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Neoplasm Staging; Prednisolone; Prognosis; Vincristine | 2018 |
A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gastrectomy; Gastroscopy; Histiocytic Sarcoma; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Recurrence, Local; Prednisolone; Retroperitoneal Space; Salvage Therapy; Stomach Neoplasms; Tomography, X-Ray Computed; Vincristine | 2018 |
[Nasal NK/T-cell lymphoma: about two rare cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nasal Obstruction; Neoplasm Staging; Nose Neoplasms; Prednisolone; Prognosis; Vincristine | 2018 |
A retrospective multicentre study of COCKLE, an oral chemotherapy regimen, as palliative treatment for high grade lymphoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lomustine; Lymphoma; Male; Palliative Care; Prednisolone; Recurrence; Retrospective Studies; Rituximab | 2019 |
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Progression-Free Survival; Retrospective Studies; Thrombocytopenia; Vincristine; Young Adult | 2019 |
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Basic-Leucine Zipper Transcription Factors; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytoplasm; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Kelch-Like ECH-Associated Protein 1; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; NF-E2-Related Factor 1; NF-E2-Related Factor 2; Predictive Value of Tests; Prednisolone; Retrospective Studies; Risk Assessment; Risk Factors; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2019 |
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Autologous; Vincristine | 2019 |
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Prednisolone; Pyridazines | 2019 |
47-Year-Old Man With Pancytopenia and Fever.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Felty Syndrome; Fever; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pancytopenia; Prednisolone; Splenomegaly; Vincristine | 2019 |
Chemotherapy-related nail toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell; Middle Aged; Nails; Nails, Malformed; Prednisolone; Vincristine | 2019 |
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Pakistan; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Vinblastine; Vincristine | 2019 |
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cisplatin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prednisolone; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Complete remission and proviral load negativization after allogeneic-SCT in a patient with Adult T-cell lymphoma: Case report.
Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisolone; Proviruses; Remission Induction; Transplantation, Homologous; Treatment Outcome; Vincristine; Viral Load | 2020 |
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lenalidomide; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prednisolone; Vincristine | 2020 |
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brown-Sequard Syndrome; Cyclophosphamide; DNA, Fungal; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Neuroaspergillosis; Opportunistic Infections; Prednisolone; Quadriplegia; Vincristine | 2020 |
Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis.
Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Disease Progression; Doxorubicin; Etoposide; Female; Histiocytic Sarcoma; Humans; Lymph Nodes; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Follicular; Middle Aged; Prednisolone; Rituximab; Translocation, Genetic; Vincristine | 2020 |
Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL).
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prednisolone; Vincristine | 2021 |
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2020 |
Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Flow Cytometry; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Skin Diseases; Vincristine | 2020 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD28 Antigens; Cyclophosphamide; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Genes, p53; Hematopoietic Stem Cell Transplantation; Humans; INDEL Mutation; Kaplan-Meier Estimate; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mutation; Nitrosourea Compounds; Polymorphism, Single Nucleotide; Prednisolone; Prednisone; Prognosis; Receptors, CCR4; Vincristine; Vindesine | 2021 |
Three dimensional and microphysiological bone marrow models detect in vivo positive compounds.
Topics: Animals; Bone Marrow; Cell Line, Tumor; Cell Survival; DNA Damage; Etoposide; Humans; Mice; Micronucleus Tests; Models, Biological; Poly(ADP-ribose) Polymerase Inhibitors; Prednisolone | 2021 |
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mitoxantrone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisolone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2021 |
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Developing Countries; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 2022 |